USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS
The present invention is directed towards the method of potentiating the anti-growth effects of type I interferon (IFN) on cells in a target cell population comprising increasing the number of functional IFNAR2c receptors on the surface of modifiedcells within the target cell population and then exp...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | VOGEL, DAVID RUSSELL-HARDE, DEAN CROZE, ED |
description | The present invention is directed towards the method of potentiating the anti-growth effects of type I interferon (IFN) on cells in a target cell population comprising increasing the number of functional IFNAR2c receptors on the surface of modifiedcells within the target cell population and then exposing the modified cells to a therapeuttically effective amount of a type I IFN or by exposure to endogenously produced IFN. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_LT2003016A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>LT2003016A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_LT2003016A3</originalsourceid><addsrcrecordid>eNqFjEEKwjAQRbtxIeoZnAsUYgvuQ5yYQJkJyYh0VUqJq6KFen8sxYU7V58H_71tMd4SAlsQh-BJMFqMTBDRYBCOUA0QuGnDQv6CYJz2BMKA5DQZXD1N4str5Ls4QGvRSFqTiwX-p5r2xebRj3M-fHdXHC2KcWWeXl2ep37Iz_zuGqmUqtXprOv_jw8AmzWo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS</title><source>esp@cenet</source><creator>VOGEL, DAVID ; RUSSELL-HARDE, DEAN ; CROZE, ED</creator><creatorcontrib>VOGEL, DAVID ; RUSSELL-HARDE, DEAN ; CROZE, ED</creatorcontrib><description>The present invention is directed towards the method of potentiating the anti-growth effects of type I interferon (IFN) on cells in a target cell population comprising increasing the number of functional IFNAR2c receptors on the surface of modifiedcells within the target cell population and then exposing the modified cells to a therapeuttically effective amount of a type I IFN or by exposure to endogenously produced IFN.</description><edition>7</edition><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20031027&DB=EPODOC&CC=LT&NR=2003016A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20031027&DB=EPODOC&CC=LT&NR=2003016A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VOGEL, DAVID</creatorcontrib><creatorcontrib>RUSSELL-HARDE, DEAN</creatorcontrib><creatorcontrib>CROZE, ED</creatorcontrib><title>USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS</title><description>The present invention is directed towards the method of potentiating the anti-growth effects of type I interferon (IFN) on cells in a target cell population comprising increasing the number of functional IFNAR2c receptors on the surface of modifiedcells within the target cell population and then exposing the modified cells to a therapeuttically effective amount of a type I IFN or by exposure to endogenously produced IFN.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjEEKwjAQRbtxIeoZnAsUYgvuQ5yYQJkJyYh0VUqJq6KFen8sxYU7V58H_71tMd4SAlsQh-BJMFqMTBDRYBCOUA0QuGnDQv6CYJz2BMKA5DQZXD1N4str5Ls4QGvRSFqTiwX-p5r2xebRj3M-fHdXHC2KcWWeXl2ep37Iz_zuGqmUqtXprOv_jw8AmzWo</recordid><startdate>20031027</startdate><enddate>20031027</enddate><creator>VOGEL, DAVID</creator><creator>RUSSELL-HARDE, DEAN</creator><creator>CROZE, ED</creator><scope>EVB</scope></search><sort><creationdate>20031027</creationdate><title>USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS</title><author>VOGEL, DAVID ; RUSSELL-HARDE, DEAN ; CROZE, ED</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_LT2003016A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>VOGEL, DAVID</creatorcontrib><creatorcontrib>RUSSELL-HARDE, DEAN</creatorcontrib><creatorcontrib>CROZE, ED</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VOGEL, DAVID</au><au>RUSSELL-HARDE, DEAN</au><au>CROZE, ED</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS</title><date>2003-10-27</date><risdate>2003</risdate><abstract>The present invention is directed towards the method of potentiating the anti-growth effects of type I interferon (IFN) on cells in a target cell population comprising increasing the number of functional IFNAR2c receptors on the surface of modifiedcells within the target cell population and then exposing the modified cells to a therapeuttically effective amount of a type I IFN or by exposure to endogenously produced IFN.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_LT2003016A |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T22%3A36%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VOGEL,%20DAVID&rft.date=2003-10-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ELT2003016A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |